Image

A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Exploring Alisertib with hormone therapy for certain breast cancer types.

Recruiting
18 years and older
All
Phase 2

This study is exploring a combination of alisertib (a drug that targets cancer cell growth) and endocrine therapy (treatment affecting hormone levels) for patients with a specific type of breast cancer. This cancer is HR-positive (hormone receptor-positive) and HER2-negative (a protein not overproduced in these cancer cells). It's intended for patients whose cancer has come back or spread after trying at least two other hormone therapies. The goal is to find the best dose of alisertib, understand how safe and effective the combination is, and identify which patients might benefit the most.

  • Length of Study: Multiple visits are required to determine the optimal dosage.
  • Eligibility: Must have tried at least two hormone therapies before.
  • Risks: Cannot have had chemotherapy or a specific type of past treatment targeting cancer growth.
Study details
    Hormone Receptor Positive HER-2 Negative Breast Cancer
    Metastatic Breast Cancer
    Recurrent Breast Cancer

NCT06369285

Puma Biotechnology, Inc.

9 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.